ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Viridian Therapeutics, Inc. ?
1
The company has declared Negative results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at USD -333.81 MM
- INTEREST(Q) Highest at USD 8.31 MM
- OPERATING PROFIT(Q) Lowest at USD -126.15 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 9.56%, its profits have fallen by -26.9%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -1.22% over the previous quarter and currently hold 7.89% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Viridian Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Viridian Therapeutics, Inc.
9.56%
1.06
71.28%
S&P 500
15.76%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
132.18%
EBIT Growth (5y)
-247.64%
EBIT to Interest (avg)
-106.87
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.02
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.88
EV to EBIT
-5.44
EV to EBITDA
-5.46
EV to Capital Employed
-19.41
EV to Sales
27.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-44.80%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
NET SALES(HY)
At USD 0.42 MM has Grown at 189.12%
NET PROFIT(HY)
Higher at USD -238.36 MM
RAW MATERIAL COST(Y)
Fallen by -118.16% (YoY
CASH AND EQV(HY)
Highest at USD 1,743.71 MM
-24What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -333.81 MM
INTEREST(Q)
Highest at USD 8.31 MM
OPERATING PROFIT(Q)
Lowest at USD -126.15 MM
PRE-TAX PROFIT(Q)
Lowest at USD -125.93 MM
NET PROFIT(Q)
Lowest at USD -125.93 MM
Here's what is working for Viridian Therapeutics, Inc.
Net Sales
At USD 0.42 MM has Grown at 189.12%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 1,743.71 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -118.16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Viridian Therapeutics, Inc.
Operating Cash Flow
Lowest at USD -333.81 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Interest
At USD 8.31 MM has Grown at 139.95%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 8.31 MM
in the last five periods and Increased by 139.95% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Profit
Lowest at USD -126.15 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -125.93 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Pre-Tax Profit
Fallen at -25.01%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -125.93 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Profit
Fallen at -25.01%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Footer loading
